Other
Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five
CVS Health Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five increased by 0.2% to $11.53B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 8.1%, from $10.67B to $11.53B.
Analysis
StatementBalance Sheet Statement
SectionOther
First reportedQ2 2019
Last reportedQ1 2026May 6, 2026
Metric ID:
other_available_for_sale_securities_debt_maturities_afte_540252Historical Data
15 periods
| Q2 '21 | Q3 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $7.4B | $7.39B | $7.04B | $6.5B | $6.26B | $6.51B | $6.94B | $7B | $7.84B | $8.78B | $10.53B | $10.67B | $11.07B | $11.51B | $11.53B |
| QoQ Change | — | -0.1% | -4.8% | -7.6% | -3.7% | +4.0% | +6.6% | +0.8% | +12.0% | +12.1% | +19.9% | +1.3% | +3.7% | +4.0% | +0.2% |
| YoY Change | — | — | — | -12.1% | -15.3% | -7.5% | +6.8% | +11.7% | +20.4% | +26.5% | +50.5% | +36.2% | +26.0% | +9.3% | +8.1% |
Range$6.26B – $11.53B
CAGR+13.5%
Avg YoY Growth+13.4%
Median YoY Growth+10.5%
Current Streak10 quarters growth
Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five at Other Companies
Frequently Asked Questions
- What is CVS Health's debt securities, available-for-sale, fair value, maturity, allocated and single maturity date, after year one through five?
- CVS Health (CVS) reported debt securities, available-for-sale, fair value, maturity, allocated and single maturity date, after year one through five of $11.53B in Q1 2026.
- How has CVS Health's debt securities, available-for-sale, fair value, maturity, allocated and single maturity date, after year one through five changed year-over-year?
- CVS Health's debt securities, available-for-sale, fair value, maturity, allocated and single maturity date, after year one through five increased by 8.1% year-over-year, from $10.67B to $11.53B.